Bacillus Subtilis (BG01-4(TM)) Improves Self-Reported Symptoms for Constipation, Indigestion, and Dyspepsia: A Phase 1/2A Randomized Controlled Trial

Background: Functional gastrointestinal disorders (FGIDs) are common, difficult-to-manage conditions. Probiotics are emerging as a dietary component that influence gastrointestinal (GI) health. We conducted a double-blinded randomised controlled trial of a proprietary strain of deactivated Bacillus...

Descripción completa

Detalles Bibliográficos
Autores principales: Patch, Craig, Pearce, Alan J., Cheng, Mek, Boyapati, Ray, Brenna, J. Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648295/
https://www.ncbi.nlm.nih.gov/pubmed/37960143
http://dx.doi.org/10.3390/nu15214490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648295/
https://www.ncbi.nlm.nih.gov/pubmed/37960143
http://dx.doi.org/10.3390/nu15214490

Ejemplares similares